Pelthos Therapeutics PTHS SEC Filings

NYSE PTHS
$23.90 -0.65 (-2.66%)
As of: Sep 9, 2026 · 3:45 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Pelthos Therapeutics Inc. (PTHS) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index